曲格列汀 T6237

Product Introduction
Bioactivity


英文名: Trelagliptin

描述: Trelagliptin (SYR-472) 是一种有效的，具有口服活性的DPP-4抑制剂，IC50=4 nM。它可以改善体内血糖控制，能够用于2 型糖尿病 (T2DM) 的研究。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : 3 mg/mL (8.39 mM)
DMSO : 66 mg/mL (184.7 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)


关键字: DPP | Diabete | SYR472 | Inhibitor | Dipeptidyl Peptidase | mellitus,?Zafatek | Trelagliptin | inhibit | Anti-diabetic | SYR 472

相关产品: Vildagliptin | Carfilzomib | AC-55541 | MG-115 | MUN57694 | Delanzomib | PSI | Bortezomib | Z-Leu-Leu-Tyr-COCHO | 20S Proteasome activator 1

相关库: Drug Repurposing Compound Library | Approved Drug Library | ReFRAME Related Library | FDA-Approved & Pharmacopeia Drug Library | Clinical Compound Library | Anti-Metabolism Disease Compound Library | Fluorochemical Library | Inhibitor Library | Highly Selective Inhibitor Library | Target-Focused Phenotypic Screening Library

曲格列汀 T6237信息由TargetMol中国为您提供，如您想了解更多关于曲格列汀 T6237报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途